Essay

A journey with scientists

Daniel M. Raben
By Daniel M. Raben
May 11, 2022

We often remember how important journeys in our lives begin. I began my journey with the American Society for Biochemistry and Molecular Biology as a graduate student at Washington University in 1976 while in the biochemistry department (now the department of biochemistry and molecular biophysics).

This department had an atmosphere of excitement and discovery among the faculty, students and postdoctoral fellows. The departmental culture encouraged the free exchange of results and ideas, and we were all excited when we had the opportunity to extend these discussions to others in our own and related fields. We had two major avenues for these exchanges: publishing our results in good journals and going to national and international meetings. The two premier platforms for such exchanges were the Journal of Biological Chemistry and the ASBMB annual meeting.

This did not change for me as a postdoctoral fellow and continued when I joined the faculty at Johns Hopkins University in 1986. The high esteem for JBC and the ASBMB annual meeting was palpable among the biochemists and molecular biologists at Hopkins. Dan Lane, director of the biological chemistry department, was elected president of the ASBMB in 1990 and championed the benefits of becoming an ASBMB member. He wasn’t wrong. As I started my career, my first-choice journal was JBC, and my go-to meeting was the ASBMB annual meeting, where I met colleagues and made friends that remain in my life to this day.

In 2010, I organized a lipid-themed session for the ASBMB meeting, and I then served as a co-chair for the 2011 meeting. It was exciting for me to learn more about how the ASBMB functions and makes decisions; I was gratified to learn that the underlying motivation was to serve scientists. This applied beyond the principal mission to help scientists disseminate and discuss their results with leaders in a variety of fields and foster new interdisciplinary collaborators. The society also has a well-oiled structure to stay abreast of important trends that affect both established investigators and trainees. These include issues such as funding, job placement and career development, minority affairs, and education.

As my career developed and my associations with the ASBMB grew, I had the opportunity to become the chair of the Meetings Committee. Not surprisingly, I saw firsthand how dedicated ASBMB members can work together to organize a great annual meeting. We had the freedom to explore new ideas and structures for the meeting, adjusting to those that worked well and jettisoning those that were less successful. While committee members held differing views on various topics, it was clear that the meeting’s success was of paramount importance. It was refreshing and reaffirming to see how folks from different areas of biochemistry and molecular biology could work synergistically to put together an exciting meeting.

In addition to my work on annual meetings, I helped establish the ASBMB Lipid Research Division with Binks Wattenberg, a professor at Virginia Commonwealth University. This division, now under the direction of George Carman and Rob Stahelin, exemplifies how the ASBMB can help foster and support a field of biochemistry occupied by many society members. Its impetus came from lipid scientists who felt this diverse field lacked a platform where investigators and trainees in its subfields could form a more cohesive community and foster collaborations. The ASBMB — in particular, Barbara Gordon, then the executive director — went above and beyond any job description to help establish this division and foster a now healthy and growing community that addresses community-specific issues.

For example, many lipid investigators felt their National Institutes of Health grant proposals were placed in study sections that lacked reviewers with the lipid expertise necessary for an adequate review. This wasn’t surprising, given the interdisciplinary nature of lipid research and its impact on a variety of fields. Consequently, lipid-related proposals often were assigned to study sections that were unfamiliar with the field. To address this, the ASBMB LRD collaborated with the NIH Center for Scientific Review and provided a list of qualified lipid scientists within the ASBMB, along with their specific expertise, who were willing and able to serve on study sections. This list was shared with the scientific review officers to help them find the necessary expertise. Given the LRD’s success, more divisions are likely to develop in the future to serve other disciplines within the ASBMB community.

The ASBMB not only has been influential in my development as a scientist but also has been instrumental in fostering a vibrant scientific community. From what I can tell, there’s a lot more excitement to come.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Daniel M. Raben
Daniel M. Raben

Daniel M. Raben is a professor at the Johns Hopkins University School of Medicine and a 2021 ASBMB fellow.

Related articles

Bonding over biochemistry
F. Peter Guengerich
The ASBMB and me
Ralph A. Bradshaw
Investing in the next generation
Nathan L. Vanderford
Discover BMB: A reimagining of our annual meeting
Karen N. Allen & Craig Cameron

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Opinions

Opinions highlights or most popular articles

Getting to know scientists half a world away
Essay

Getting to know scientists half a world away

April 24, 2024

In a program at Wellesley College, students interview and write about researchers at a university in Ghana.

Let’s make ASBMB awardees look more like BMB scientists
Award

Let’s make ASBMB awardees look more like BMB scientists

April 23, 2024

Think about nominating someone outside your immediate network.

A paleolithic peer review
Essay

A paleolithic peer review

April 18, 2024

You might think review panels have only been around for the last century or so. You would be mistaken.

Early COVID-19 research is riddled with poor methods and low-quality results
News

Early COVID-19 research is riddled with poor methods and low-quality results

April 13, 2024

The pandemic worsened, but didn’t create, this problem for science.

So, you went to a conference. Now what?
Professional Development

So, you went to a conference. Now what?

April 12, 2024

Once you return to normal lab life, how can you make use of everything you learned?

My guitar companion
Essay

My guitar companion

April 11, 2024

A scientist takes a musical journey through time and around the world.